Literature DB >> 2014104

Posterior chamber IOL implantation with suboptimal posterior capsular support.

W E Smiddy1, R Avery.   

Abstract

A posterior chamber intraocular lens (PC/IOL) was implanted in 24 patients with suboptimal posterior capsular support due to preoperative or intraoperative rupture of the posterior capsule or zonules in which at least six clock hours of peripheral zonular support remained. The PC/IOLs were implanted, with ciliary sulcus haptic placement, with special attention to sulcus fixation of the haptics over the zone of residual zonular support. All of the IOLs have remained centered after a mean follow-up 10.5 months. We conclude that a PC/IOL can be successfully implanted and its position maintained if at least six clock hours of peripheral zonules remain.

Entities:  

Mesh:

Year:  1991        PMID: 2014104

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  4 in total

1.  Effects of posterior capsular disruption on the outcome of phacoemulsification surgery.

Authors:  M Mulhern; G Kelly; P Barry
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

2.  Pathologic comparison of asymmetric or sulcus fixation of 3-piece intraocular lenses with square versus round anterior optic edges.

Authors:  Andrew Ollerton; Liliana Werner; Susan Strenk; Lawrence Strenk; Lisa Leishman; Zachary Bodnar; Kevin R Kirk; Jennifer Michelson; Nick Mamalis
Journal:  Ophthalmology       Date:  2013-04-16       Impact factor: 12.079

3.  Tilt and decentration of an intraocular lens implanted in the ciliary sulcus after capsular bag defect during cataract surgery.

Authors:  Thomas Sauer; Ulrich Mester
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-02       Impact factor: 3.117

4.  Long-term outcomes of ciliary sulcus versus capsular bag fixation of intraocular lenses in children: An ultrasound biomicroscopy study.

Authors:  Yun-E Zhao; Xian-Hui Gong; Xue-Ning Zhu; He-Ming Li; Meng-Jun Tu; Terry G Coursey; Stephen C Pflugfelder; Feng Gu; Ding Chen
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.